Abstract
Copper (Cu) transporters emerged as key factors at the basis of the biological response to antitumor platinum (Pt) drugs, which are among the most potent and broadly used chemotherapeutics. ATP7A and ATP7B (the Menkes and Wilson disease proteins, respectively) appear to be implicated in promoting tumor cell resistance to cisplatin. Cu-ATPases could bind the drug and, with the alleged involvement of the chaperone ATOX1, contribute to cell detoxification and survival. Here, we report the spectroscopic characterization of cisplatin binding to ATOX1 and MNK1, the first metal-binding domain of ATP7A, in the presence of the physiological reducing agent glutathione, a sulfur-containing molecule responsible for the majority of Pt detoxification in the cytosol. Under conditions mimicking the cellular environment, we show that cisplatin transfer from ATOX1 to MNK1 does not occur at a detectable rate. These results appear to contradict other literature data which, however, were obtained in the presence of exogenous reducing agents such as tris(2-carboxyethyl)phosphine (TCEP) having good coordinating ability for soft metal ions (such as Pt) and strong trans-labilizing effect. A better understanding of Pt drug processing by Cu trafficking proteins under physiological conditions may help to answer key issues, such as drug availability in tumor cells and resistance.
Similar content being viewed by others
Abbreviations
- MBD:
-
Metal-binding domain
- GSH:
-
Glutathione
- TCEP:
-
Tris(2-carboxyethyl)phosphine
- DTT:
-
Dithiothreitol
- NMR:
-
Nuclear magnetic resonance
- ESI–MS:
-
Electrospray ionization mass spectrometry
References
Howell SB, Safaei R, Larson CA, Sailor MJ (2010) Mol Pharmacol 77:887–894
Arnesano F, Losacco M, Natile G (2013) Eur J Inorg Chem, pp 2701–2711
Arnesano F, Natile G (2009) Coord Chem Rev 253:2070–2081
Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467–2498
Rabik CA, Dolan ME (2007) Cancer Treat Rev 33:9–23
Shen DW, Pouliot LM, Hall MD, Gottesman MM (2012) Pharmacol Rev 64:706–721
Chen HH, Kuo MT (2010) Met Based Drugs, p 2010
Kasherman Y, Sturup S, Gibson D (2009) J Med Chem 52:4319–4328
Ishikawa T, li-Osman F (1993) J Biol Chem 268:20116–20125
Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T (2007) Cancer Metastasis Rev 26:71–83
Katano K, Safaei R, Samimi G et al (2004) Clin Cancer Res 10:4578–4588
Safaei R, Otani S, Larson BJ, Rasmussen ML, Howell SB (2008) Mol Pharmacol 73:461–468
Safaei R, Maktabi MH, Blair BG, Larson CA, Howell SB (2009) J Inorg Biochem 103:333–341
Hua H, Gunther V, Georgiev O, Schaffner W (2011) Biometals 24:445–453
Lutsenko S (2010) Curr Opin Chem Biol 14:211–217
Lutsenko S, LeShane ES, Shinde U (2007) Arch Biochem Biophys 463:134–148
Arnesano F, Banci L, Bertini I et al (2002) Genome Res 12:255–271
Itoh S, Ozumi K, Kim HW et al (2008) Free Radic Biol Med 46:95–104
Itoh S, Kim HW, Nakagawa O et al (2008) J Biol Chem 283:9157–9167
Arnesano F, Banci L, Bertini I, Felli IC, Losacco M, Natile G (2011) J Am Chem Soc 133:18361–18369
Boal AK, Rosenzweig AC (2009) J Am Chem Soc 131:14196–14197
Dolgova NV, Olson D, Lutsenko S, Dmitriev OY (2009) Biochem J 419:51–56
Palm-Espling ME, Wittung-Stafshede P (2012) Biochem Pharmacol 83:874–881
Palm ME, Weise CF, Lundin C et al (2011) Proc Natl Acad Sci USA 108:6951–6956
Dolgova NV, Nokhrin S, Yu CH, George GN, Dmitriev OY (2013) Biochem J 454:147–156
Safaei R, Adams PL, Maktabi MH, Mathews RA, Howell SB (2012) J Inorg Biochem 110:8–17
Mangala LS, Zuzel V, Schmandt R et al (2009) Clin Cancer Res 15:3770–3780
Palm-Espling ME, Andersson CD, Bjorn E, Linusson A, Wittung-Stafshede P (2013) PLoS ONE 8:e70473
Banci L, Bertini I, Cantini F, Della Malva N, Migliardi M, Rosato A (2007) J Biol Chem 282:23140–23146
Rae T, Schmidt PJ, Pufahl RA, Culotta VC, O’Halloran TV (1999) Science 284:805–808
Dhara S (1970) Indian J Chem 8:193–194
Berners-Price SJ, Ronconi L, Sadler PJ (2006) Prog Nucl Magn Reson Spectrosc 49:65–98
Gibson D, Kasherman Y, Kowarski D, Freikman I (2006) J Biol Inorg Chem 11:179–188
Xi Z, Guo W, Tian C, Wang F, Liu Y (2013) Chem Commun (Camb) 49:11197–11199
Arnesano F, Scintilla S, Natile G (2007) Angew Chem Int Ed Engl 46:9062–9064
Nguyen TH, Arnesano F, Scintilla S et al (2012) J Chem Theory Comput 8:2912–2920
Xiao Z, Wedd AG (2002) Chem Commun (Camb) 6:588–589
Banci L, Bertini I, Cantini F, Massagni C, Migliardi M, Rosato A (2009) J Biol Chem 284:9354–9360
Tadini-Buoninsegni F, Bartolommei G, Moncelli MR et al (2014) Angew Chem Int Ed Engl 53:1297–1301
Acknowledgments
We are grateful to the University of Bari “Aldo Moro”, the Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), the Italian Ministero dell’Università e della Ricerca (MIUR, PON 01078), and the European Commission (COST Action CM1105) for funding and support.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Responsible Editors: Lucia Banci and Claudio Luchinat.
This paper is dedicated to the memory of Ivano Bertini (1940–2012).
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Galliani, A., Losacco, M., Lasorsa, A. et al. Cisplatin handover between copper transporters: the effect of reducing agents. J Biol Inorg Chem 19, 705–714 (2014). https://doi.org/10.1007/s00775-014-1138-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-014-1138-1